BLRX, BioLineRx Ltd.

** BLRX reported that it has signed a worldwide, exclusive license agreement with Genoscience, a French company focused on viral disease therapeutics, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.

TearLab Corporation (Nasdaq:TEAR) announced that it has closed its previously announced private placement of approximately 3.85 million units at a price of $1.82 per unit. Each unit consisted of one share of common stock and a warrant to purchase one share of common stock at an exercise price of US$1.86 per share. The Company has received total gross proceeds of approximately US$7 million.

Cleantech Transit Inc. (CLNO)

With the recent and continued increase in wind power, the challenge is clear: how can the energy industry integrate this intermittent power source into the electricity grid?

**************************************************************

PROTEONOMIX, INC. (OTC.BB:PROT), has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.